Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$425M |
| 2 |
Texas Instruments
TXN
|
+$403M |
| 3 |
AbbVie
ABBV
|
+$296M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$251M |
| 5 |
Meta Platforms (Facebook)
META
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$948M |
| 2 |
Gilead Sciences
GILD
|
+$701M |
| 3 |
SLB Ltd
SLB
|
+$520M |
| 4 |
Qualcomm
QCOM
|
+$273M |
| 5 |
AT&T
T
|
+$213M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 15.29% |
| 3 | Financials | 12.28% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Liquidity Services
LQDT
$1.35B
| $1.02M | ﹤0.01% |
264,189
-22,725
| -8% | -$108K |
|
|
BVH
2902
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $1.02M | ﹤0.01% |
88,583
+14,908
| +20% | +$253K |
|
2903
United States Lime & Minerals
USLM
$3.42B
| $1.02M | ﹤0.01% |
69,175
-2,000
| -3% | -$33.4K |
|
2904
Shore Bancshares
SHBI
$801M
| $1.02M | ﹤0.01% |
94,019
-911
| -1% | -$13.3K |
|
|
NGM
2905
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.01M | ﹤0.01% |
82,295
+23,567
| +40% | +$385K |
|
|
GTT
2906
DELISTED
GTT Communications, Inc.
GTT
| $1.01M | ﹤0.01% |
127,623
-5,960
| -4% | -$72K |
|
2907
Banco Santander
SAN
$211B
| $1.01M | ﹤0.01% |
447,861
+76,780
| +21% | +$263K |
|
|
QEP
2908
DELISTED
QEP RESOURCES, INC.
QEP
| $1.01M | ﹤0.01% |
3,008,158
-935,651
| -24% | -$2.25M |
|
|
AXDX
2909
DELISTED
Accelerate Diagnostics
AXDX
| $1M | ﹤0.01% |
12,076
+165
| +1% | +$23.2K |
|
2910
Saga Communications
SGA
$64.6M
| $1M | ﹤0.01% |
36,502
+10,663
| +41% | +$314K |
|
|
WTRE
2911
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $1M | ﹤0.01% |
68,517
+386
| +0.6% | +$8.47K |
|
2912
Carter Bankshares
CARE
$749M
| $999K | ﹤0.01% |
108,878
+2,217
| +2% | +$37.8K |
|
2913
Geron
GERN
$982M
| $998K | ﹤0.01% |
838,962
+23,515
| +3% | +$28.8K |
|
2914
BGSF Inc
BGSF
$57.6M
| $997K | ﹤0.01% |
133,265
-6,441
| -5% | -$108K |
|
2915
CALL
GE Aerospace
GE
$374B
| $996K | ﹤0.01% |
25,180
| – | – |
|
|
GNMK
2916
DELISTED
GenMark Diagnostics, Inc
GNMK
| $994K | ﹤0.01% |
241,259
-224
| -0.1% | -$1.05K |
|
|
JNCE
2917
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $993K | ﹤0.01% |
209,007
-11,124
| -5% | -$64K |
|
|
IBDP
2918
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| $992K | ﹤0.01% |
40,167
+3,193
| +9% | +$81.2K |
|
2919
Parke Bancorp
PKBK
$409M
| $990K | ﹤0.01% |
73,391
+2,148
| +3% | +$40.7K |
|
2920
BlackRock Health Sciences Trust II
BMEZ
$1.01B
| $988K | ﹤0.01% |
+55,200
| New | +$1.06M |
|
|
RYZ
2921
Ryerson Holding Corp
RYZ
$1.5B
| $988K | ﹤0.01% |
185,868
-4,441
| -2% | -$39.2K |
|
2922
Phathom Pharmaceuticals
PHAT
$743M
| $987K | ﹤0.01% |
38,233
+13,439
| +54% | +$449K |
|
2923
PagSeguro Digital
PAGS
$2.43B
| $983K | ﹤0.01% |
50,838
+13,862
| +37% | +$421K |
|
2924
First Northwest Bancorp
FNWB
$107M
| $977K | ﹤0.01% |
89,883
-1,360
| -1% | -$20.8K |
|
|
CDMO
2925
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $977K | ﹤0.01% |
191,055
-8,431
| -4% | -$51K |
|
Similar funds
Bank of New York Mellon's Q1 2020 Portfolio in Review
As of Q1 2020, Bank of New York Mellon held 4,289 positions worth $302B, down 22% from $388B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q1 2020 filing shows 113 new, 1,571 increased, 2,175 reduced and 192 closed positions. Its largest new stake was 1Life Healthcare: 2,014,468 shares worth $36.6M. The largest sale was Starbucks, an estimated $948M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2020 buy was 1Life Healthcare: 2,014,468 shares worth $36.6M.
- Bank of New York Mellon added most to Illumina in Q1 2020, an estimated $425M increase.
- Bank of New York Mellon's biggest Q1 2020 reduction was Starbucks, cutting an estimated $948M.
- Bank of New York Mellon fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $170M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $302B portfolio in Q1 2020.
- Bank of New York Mellon opened 113 new positions and closed 192 in Q1 2020.
- Bank of New York Mellon's portfolio value fell 22% quarter-over-quarter to $302B.
Based on Bank of New York Mellon's 13F filing for Q1 2020, filed 6 May 2020.